Purigen Biosystems Revenue and Competitors
Estimated Revenue & Valuation
- Purigen Biosystems's estimated annual revenue is currently $1.2M per year.
- Purigen Biosystems's estimated revenue per employee is $77,500
- Purigen Biosystems's total funding is $93.1M.
Employee Data
- Purigen Biosystems has 16 Employees.
- Purigen Biosystems grew their employee count by -61% last year.
Purigen Biosystems's People
| Name | Title | Email/Phone |
|---|
Purigen Biosystems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Purigen Biosystems?
Purigen Biosystems'? transformative platform provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field-driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. Purigen's system is compatible with a range of samples. This includes mammalian cells, FFPE and FNA tissue biopsies, plasma, blood, and buccal swabs.
keywords:N/A
$93.1M
Total Funding
16
Number of Employees
$1.2M
Revenue (est)
-61%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Purigen Biosystems News
--(BUSINESS WIRE)--Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from...
The Ionic® Purification System from Purigen Biosystems enables researchers to extract higher yields of purified DNA and RNA from challenging...
Purigen Biosystems, Inc., a Pleasanton, Calif.-based provider of next-generation technologies for extracting, enriching, and quantifying nucleic acids from biological samples, closed a $26.4m Series B financing. The round was led by Agilent Technologies with participation from new investor Cota ...
Purigen Biosystems, a Pleasanton, CA-based developer of technology for genomics sample preparation, completed an $18.2M Series A funding. Backers included 5AM Ventures, Roche Venture Fund and existing investors the Stanford-Startx Fund and Western Investments Capital. Under the terms of the fin ...
Other Companies in Pleasanton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 16 | 7% | N/A |
#2 | $1.4M | 16 | -27% | N/A |
#3 | $2.5M | 16 | 0% | N/A |
#4 | $2.2M | 16 | N/A | N/A |
#5 | $1.4M | 16 | 0% | N/A |